SCHEMBL7658175

SCHEMBL7658175

CC(=O)Nc1ccc(Cl)c2c1C(=O)C(NC(C)=O)CS2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ALDH1A1 P00352 3/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
ABL1 P00519 3/20 0.34
MAPT P10636 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
HSD17B10 Q99714 2/20 0.33
MAOA P21397 1/20 0.33
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7660534 0.86 KDM4E (0.37) KDM4EHPGDRAB9ASMN1; SMN2NPSR1
SCHEMBL7659454 0.84 KDM4E (0.38) KDM4EHPGDRAB9ASMN1; SMN2NPSR1
SCHEMBL7658951 0.81 HDAC1 (0.35) KDM4EHPGDRAB9ASMN1; SMN2NPSR1
SCHEMBL7655843 0.77 KDM4E (0.43) KDM4EHPGDRAB9ASMN1; SMN2NPSR1
SCHEMBL26672573 0.76 KDM4E (0.35) KDM4ESMN1; SMN2NPSR1CA1CA2
SCHEMBL7657838 0.74 ALDH1A1 (0.38) KDM4EHPGDRAB9ASMN1; SMN2ALDH1A1
SCHEMBL7660832 0.73 ATAD2 (0.34) KDM4ESMN1; SMN2ALDH1A1CA1CA2
SCHEMBL7664370 0.69 LMNA (0.49) KDM4EHPGDRAB9ANPSR1ALDH1A1
SCHEMBL7655413 0.69 KDM4E (0.35) KDM4EHPGDRAB9ASMN1; SMN2NPSR1
SCHEMBL7661668 0.66 KDM4E (0.38) KDM4EHPGDRAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407115-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS; SIDE EFFECT REDUCTION, WATER SOLUBILITY DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-06-18 US disclosed
US-5834476-A DERIVATIVE OF CAMPTOTHECIN, ANTITUMOR AGENT, ANTICARCINOGENIC AGENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
US-5770605-A Method for treating leukemia with a hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-23 US disclosed
US-5658920-A ANTITUMOR AGENTS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-08-19 US disclosed
US-5637770-A Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-10 US disclosed
EP-0495432-B1 Hexa-cyclic compound DAIICHI SEIYAKU CO (JP) 1996-05-29 EP disclosed
EP-0495432-A1 Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1992-07-22 EP disclosed